相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Population pharmacokinetic and pharmacodynamic analyses from a 4-month intradose escalation and its subsequent 12-month dose titration studies for a human monoclonal anti-FGF23 antibody (KRN23) in adults with X-linked hypophosphatemia
Xiaoping Zhang et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2016)
Pharmacokinetics and Pharmacodynamics of a Human Monoclonal Anti-FGF23 Antibody (KRN23) in the First Multiple Ascending-Dose Trial Treating Adults With X-Linked Hypophosphatemia
Xiaoping Zhang et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2016)
Nationwide survey of fibroblast growth factor 23 (FGF23)-related hypophosphatemic diseases in Japan: prevalence, biochemical data and treatment
Itsuro Endo et al.
ENDOCRINE JOURNAL (2015)
Prolonged Correction of Serum Phosphorus in Adults With X-Linked Hypophosphatemia Using Monthly Doses of KRN23
Erik A. Imel et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2015)
Randomized trial of the anti-FGF23 antibody KRN23 in X-linked hypophosphatemia
Thomas O. Carpenter et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Incidence and prevalence of nutritional and hereditary rickets in southern Denmark
Signe Sparre Beck-Nielsen et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2009)
Therapeutic Effects of Anti-FGF23 Antibodies in Hypophosphatemic Rickets/Osteomalacia
Yukiko Aono et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2009)
分享论文
